William O'Neill, MD, shares insights from the National Cardiogenic Shock Initiative (NCSI) Study that are driving improved outcomes in patients with AMI cardiogenic shock.
Duane Pinto, MD, MPH, discusses the new single access technique, designed to avoid an additional arterial access, and reduce associated complications as well as make the procedure more rapid.
Learn when and how to use echocardiography to visualize in real-time the relationship of the Impella 5.5 with SmartAssist to structures within the left ventricle.
Ameloot et al. report significant reduction in myocardial injury with target MAP between 80/85 and 100 mmHg in post-cardiac arrest patients with shock after AMI.
This FAQ discusses the PROTECT series of FDA clinical studies, which include the PROTECT I study, the PROTECT II randomized controlled trial, and the PROTECT III study.
Understanding how to utilize and interpret LV waveforms displayed on the Automated Impella Controller™ can assist with troubleshooting suction events and aid in timely resolution.
Yoshiki Sawa, MD, PhD, discusses a large multicenter study in Japan demonstrating high survival rates in AMI cardiogenic shock patients receiving the Impella heart pump.
